Tomas Jörgen Eriksson
Direttore/Membro del Consiglio presso PROSTALUND AB
Profilo
Tomas Jörgen Eriksson founded Preelumina AB in 2008, where he is working as Chief Executive Officer from 2008 and Guard Therapeutics International AB in 2008, where he worked as Chief Executive Officer from 2008 to 2019.
Mr. Eriksson also currently works at Sinntaxis AB, as Chief Executive Officer from 2019, Omnio AB, as Chairman, Kombinator Affärsutveckling AB, as Director from 2008, Swede Unipharma AB, as Director, and ProstaLund AB, as Independent Director from 2023.
Mr. Eriksson also formerly worked at Lund University Bioscience AB, as Chief Executive Officer, Preelumina Diagnostics AB, as Chairman & Chief Executive Officer, Merozyne Therapeutics AB, as Chairman, WC Likvid AB, as Director, Nordic Bioscience A, as Sales Director from 2001 to 2004, Sista versen 26366 AB, as Director, Finja Five AB, as Director, Enorama Pharma AB, as Independent Director, Termino C 2436 AB, as Director, Magle AB, as Director-Sales & Marketing, Magle Life Sciences AB, as Director-Sales & Marketing, and Gambro AB, as Area Manager.
Mr. Eriksson received his undergraduate degree from the University of Lund.
Posizioni attive di Tomas Jörgen Eriksson
| Società | Posizione | Inizio |
|---|---|---|
| PROSTALUND AB | Direttore/Membro del Consiglio | 12/10/2023 |
Preelumina AB
 Preelumina AB Pharmaceuticals: MajorHealth Technology PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden. | Amministratore Delegato | 03/06/2010 |
| Kombinator Affärsutveckling AB | Direttore/Membro del Consiglio | 01/01/2008 |
Sinntaxis AB
 Sinntaxis AB Miscellaneous Commercial ServicesCommercial Services Sinntaxis AB conducts research and development in neurosciences and pharmaceutical drugs. The company is based in Lund, Sweden. The CEO of the Swedish company is Tomas Jörgen Eriksson. | Amministratore Delegato | 01/04/2019 |
Swede Unipharma AB
 Swede Unipharma AB Financial ConglomeratesFinance Swede Unipharma AB provides investment services. The Swedish company was founded by Mats Otto Persson. | Direttore/Membro del Consiglio | - |
Omnio AB
 Omnio AB BiotechnologyHealth Technology Omnio AB is a biotechnical research and Swedish development company. The private company is based in Umeå, Sweden. | Presidente | - |
Precedenti posizioni note di Tomas Jörgen Eriksson
| Società | Posizione | Fine |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Amministratore Delegato | 15/01/2019 |
Nordic Bioscience A/S
 Nordic Bioscience A/S Miscellaneous Commercial ServicesCommercial Services Nordic Bioscience A/S engages in preclinical and clinical drug development. It specializes in precision medicine using biomarker technologies. The company was founded by Claus Henrik Christiansen and Bente Juel Riis in 1991 and is headquartered in Herlev, Denmark. | Vendite & Marketing | 01/01/2004 |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Tomas Jörgen Eriksson
| University of Lund | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| ENORAMA PHARMA AB | Health Technology |
| PROSTALUND AB | Health Technology |
| Aziende private | 15 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
WC Likvid AB
 WC Likvid AB Real Estate DevelopmentFinance WC Likvid AB owns and manages movable and immovable property. The company was founded by Tadeusz Wojciech Wieloch on June 5, 2009 and is headquartered in Staffanstorp, Sweden. | Finance |
Nordic Bioscience A/S
Nordic Bioscience A/S Miscellaneous Commercial ServicesCommercial Services Nordic Bioscience A/S engages in preclinical and clinical drug development. It specializes in precision medicine using biomarker technologies. The company was founded by Claus Henrik Christiansen and Bente Juel Riis in 1991 and is headquartered in Herlev, Denmark. | Commercial Services |
Sista versen 26366 AB
 Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Health Technology |
Finja Five AB
 Finja Five AB Information Technology ServicesTechnology Services Finja Five AB develops and manages the concept child-friendly-computing (CFC) for schools and at home. It operates as a knowledge enterprise within the business segment of information and communication technology (ICT). The firm’s main business is CFC for emerging markets, globally. The company was founded in 2008 and is headquartered in Lund, Sweden. | Technology Services |
| Preelumina Diagnostics AB | |
Magle AB
 Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The company is based in Lund, Sweden. | Process Industries |
Omnio AB
Omnio AB BiotechnologyHealth Technology Omnio AB is a biotechnical research and Swedish development company. The private company is based in Umeå, Sweden. | Health Technology |
Merozyne Therapeutics AB
 Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Health Technology |
Swede Unipharma AB
Swede Unipharma AB Financial ConglomeratesFinance Swede Unipharma AB provides investment services. The Swedish company was founded by Mats Otto Persson. | Finance |
Sinntaxis AB
Sinntaxis AB Miscellaneous Commercial ServicesCommercial Services Sinntaxis AB conducts research and development in neurosciences and pharmaceutical drugs. The company is based in Lund, Sweden. The CEO of the Swedish company is Tomas Jörgen Eriksson. | Commercial Services |
| Magle Life Sciences AB | |
Preelumina AB
Preelumina AB Pharmaceuticals: MajorHealth Technology PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden. | Health Technology |
Termino C 2436 AB
 Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Health Technology |
| Kombinator Affärsutveckling AB |
- Borsa valori
- Insiders
- Tomas Jörgen Eriksson
